Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2025)

Revolution Medicines (RVMD) has 7 years of Amortizatization of Intangibles data on record, last reported at $7.0 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 83.4% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $7.9 million, down 82.26%, while the annual FY2025 figure was $7.9 million, 82.26% down from the prior year.
  • Amortizatization of Intangibles reached $7.0 million in Q4 2025 per RVMD's latest filing, up from $300000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $42.4 million in Q4 2024 and bottomed at -$13.4 million in Q2 2024.
  • Average Amortizatization of Intangibles over 5 years is $2.8 million, with a median of $300000.0 recorded in 2021.
  • The widest YoY moves for Amortizatization of Intangibles: up 4981.33% in 2024, down 1383.52% in 2024.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$3.8 million in 2021, then soared by 131.01% to $1.2 million in 2022, then skyrocketed by 102.96% to $2.4 million in 2023, then skyrocketed by 1668.28% to $42.4 million in 2024, then crashed by 83.4% to $7.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $7.0 million in Q4 2025, $300000.0 in Q3 2025, and $300000.0 in Q2 2025.